People in diverse corners of healthcare are hopeful new legislation will ease growing consumer anxiety over higher medical deductibles. And it might have a chance of becoming law because the cause comes from rare bipartisan ground.
South Carolina's Lexington Medical Center will pay the government $17 million over allegations that it paid 28 physicians unreasonably high amounts in exchange for referrals.
A list of the 20 largest healthcare merger-and-acquisition deals through June 2016, ranked by announced purchase price based on Modern Healthcare reporting. Source: Modern Healthcare Mergers & Acquisitions premium database. Published July 25, 2016, p. 34.
UPMC will pay the government $2.5 million to settle allegations that its neurosurgeons submitted claims to Medicare for surgeries performed by others.
Molina Healthcare beat profit expectations in the second quarter following a brutal start to the year, but the Medicaid managed-care insurer still reported lower overall net income.
Two key players in the passage of the ACA warn that if Donald Trump becomes president, he and congressional Republican leaders could indeed abolish key elements of the law and roll back its insurance expansions and consumer protections.
A $650 million investment that HCA is making at its east Florida hospitals illustrates how HCA is trying to stay ahead of a patient shift to outpatient services with hospitals being reserved for high-acuity care, HCA executives said during an earnings call Thursday.
Implementing new or different EHR systems had negligible short-term effects on readmission or mortality rates across a 17-hospital sample, according to a study published in the BMJ. The new or different information technology also had no statistically significant adverse impact on patient safety.
The CMS published the much-anticipated Overall Hospital Quality Star Ratings on Wednesday after industry stakeholders and Congress pressured the agency to continue to delay their release. See a complete, searchable list at the bottom of this story.
Lilly CEO John Lechleiter will retire in December after leading the drugmaker through a challenging period in which it lost U.S. patent protection for several top-selling products. David Ricks, president of its biomedicines business, will replace Lechleiter in January.
We asked readers to vote for up to 10 innovations. These are the 25 that garnered the most votes, including storefront healthcare, bionic limbs and primary-care access.